We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use °Ç¸ç³Ô¹Ï, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
We help UK life sciences companies to do business overseas and support foreign life sciences companies to invest in the UK.
Guide for overseas investors on how to access NHS procurement channels.
Overview of organisations supporting life sciences in the UK, organised by sub-sector and stage of product or service development.
Introduction to UK digital health and care The National Health Service…
Introduction to experimental medicine and clinical trials The UK offers a…
Introduction to medical technology The UK medical technology sector is a…
Introduction to medicines manufacturing Tomorrow’s medicines will demand…
Introduction to precision medicine and genomics Globally, there is a…
Introduction to regenerative medicine, cell and gene therapy Regenerative…
UK life sciences trade organisations, membership associations, clusters,…
Overview of UK research infrastructure for genomics technologies, and advantages of investment in the UK's life science sector to support new products.
Overview of the UK's diabetes research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
Overview of the UK's cell and gene therapy research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
Overview of the UK's advanced wound-care research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
Overview of the UK's antimicrobial resistance (AMR) research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
Overview of the UK's cardiovascular disease research infrastructure and advantage of investment in the UK's life science sector to support new treatments.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve °Ç¸ç³Ô¹Ï, we’d like to know more about your visit today. .